Axsome Therapeutics, Inc. 10-Q filing
Filed 2025-11-03 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-262664
- Form type
- 10-Q
- CIK
- 0001579428
- Primary document
- https://www.sec.gov/Archives/edgar/data/1579428/000119312525262664/axsm-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Axsome Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $442.5M | - | - |
| Operating Income | $-139.8M | - | - |
| Net Income | $-154.6M | - | - |
| Eps Basic | -3.13 | - | - |
| Eps Diluted | -3.13 | - | - |
| Cash And Equivalents | $325.3M | - | - |
| Total Assets | $669.3M | - | - |
| Total Liabilities | $595.5M | - | - |
| Shareholders Equity | $73.7M | - | - |
| Operating Cash Flow | $-74.8M | - | - |
| Capital Expenditures | $409,000 | - | - |